Evidence brief · printable

Parkinson Disease evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Parkinson Disease: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 2,379 matching trials) · https://research.opensourcemed.info/briefs/parkinson-disease.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • BIA 9-1067 2 trials
  • Entacapone 2 trials
  • HER-096 2 trials
  • Istradefylline 2 trials
  • Levodopa 2 trials
  • ND0611 (see NCT01103011) 2 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Transcranial brain stimulation (tDCS, TMS) 74 trials · 25 completed · 6 with results
  • Psychotherapy, counselling and peer support 13 trials · 9 completed · 4 with results
  • Aerobic and endurance exercise 39 trials · 20 completed · 3 with results
  • Education, coaching and self-management 17 trials · 7 completed · 2 with results
  • Physiotherapy and physical therapy 20 trials · 6 completed · 2 with results
  • Peripheral electrical and electromagnetic stimulation 7 trials · 3 completed · 2 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Vitamin D3
  • Creatine
  • Coenzyme Q10
  • Mucuna Pruriens
  • D-Serine

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Prevent Cognitive Decline in GBA-associated Parkinson's Disease NCT07055087
  • A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients. NCT07630545
  • A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With… NCT06565195
  • Mid-frontal Delta/Theta and Cognitive Control NCT06984757
  • Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage NCT06993142
  • Effectiveness of TeleVR App in Cognitive Decline and MCI Patients NCT06793735

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Other devices and digital tools: physical function and exercise capacity 13 trials, no results posted yet
  • Neuromodulation and electrical stimulation: cognition 11 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (490 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.